A detailed history of Deep Track Capital, LP transactions in Verona Pharma PLC stock. As of the latest transaction made, Deep Track Capital, LP holds 3,180,025 shares of VRNA stock, worth $144 Million. This represents 3.37% of its overall portfolio holdings.

Number of Shares
3,180,025
Previous 4,000,000 20.5%
Holding current value
$144 Million
Previous $57.8 Million 58.18%
% of portfolio
3.37%
Previous 1.9%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.46 - $30.16 $12.7 Million - $24.7 Million
-819,975 Reduced 20.5%
3,180,025 $91.5 Million
Q2 2024

Aug 14, 2024

BUY
$11.48 - $17.02 $9.33 Million - $13.8 Million
812,585 Added 25.49%
4,000,000 $57.8 Million
Q4 2022

Feb 14, 2023

BUY
$9.84 - $26.13 $3.53 Million - $9.36 Million
358,321 Added 12.67%
3,187,415 $83.3 Million
Q3 2022

Nov 14, 2022

BUY
$4.14 - $13.59 $11.7 Million - $38.4 Million
2,829,094 New
2,829,094 $28.9 Million

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $2.76B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.